Latest Breaking News On - Carter lewis gould - Page 1 : comparemela.com

Pfizer execs discuss hiking vaccine price after pandemic wanes By Audrey McNamara Pfizer and Moderna ramping up vaccine supplies A top executive for Pfizer suggested to investors last week that pricing for its COVID-19 vaccine could increase post-pandemic. The suggestion raises questions about whether a drug, developed at the behest of the federal government to respond to a global crisis, could turn a profit for one company. The possibility was raised by Carter Lewis Gould, a senior analyst for Biopharma Equity Research at Barclays, during a virtual global healthcare conference hosted by the bank. Gould, referencing comments made by Pfizer executives over the summer, asked how the pharmaceutical company still envisioned pursuing higher pricing as we move from a pandemic to an endemic phase, according to an edited transcript of the conversation. 

New yorkUnited statesKathrin jansenCarter lewis gouldXavier becerraFranka damelioNorris cochranJoe bidenUs centers for diseaseHuman servicesBiopharma equity research at barclaysNational institutes of healthAdvisory committee on immunization practicesNew york timesUniversity of chicagoBiopharma equity research